Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $451.80 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARBOR PHARMACEUTICALS, INC. | $128.22 | 17 | $0 (2018) |
| OptiNose US, Inc. | $85.30 | 4 | $0 (2020) |
| Mylan Specialty L.P. | $44.73 | 2 | $0 (2018) |
| Merck Sharp & Dohme LLC | $31.09 | 2 | $0 (2023) |
| ALK-Abello, Inc | $27.07 | 2 | $0 (2021) |
| GENZYME CORPORATION | $23.03 | 1 | $0 (2023) |
| Olympus America Inc. | $20.69 | 1 | $0 (2018) |
| Philips Electronics North America Corporation | $17.34 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $16.60 | 1 | $0 (2023) |
| Smith+Nephew, Inc. | $16.26 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $70.72 | 4 | Merck Sharp & Dohme LLC ($31.09) |
| 2022 | $11.80 | 1 | Hikma Pharmaceuticals USA ($11.80) |
| 2021 | $27.07 | 2 | ALK-Abello, Inc ($27.07) |
| 2020 | $78.26 | 4 | OptiNose US, Inc. ($46.70) |
| 2019 | $22.66 | 1 | OptiNose US, Inc. ($22.66) |
| 2018 | $181.53 | 19 | ARBOR PHARMACEUTICALS, INC. ($116.97) |
| 2017 | $59.76 | 4 | Philips Electronics North America Corporation ($17.34) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 10/05/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $14.48 | General |
| 08/30/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $16.61 | General |
| 11/16/2022 | Hikma Pharmaceuticals USA | Kloxxado (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/05/2021 | ALK-Abello, Inc | Otiprio (Drug), Odactra, Grastek | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Otolaryngology | ||||||
| 03/18/2021 | ALK-Abello, Inc | Otiprio (Drug), Odactra, Grastek | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Otolaryngology | ||||||
| 12/08/2020 | Smith+Nephew, Inc. | TULA System (Device) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: ENT | ||||||
| 08/19/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/11/2020 | PFIZER INC. | THROMBIN-JMI (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: HEMOSTAT | ||||||
| 02/24/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/03/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/28/2018 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Pediatrics/Neonatology | ||||||
| 11/14/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: Pediatrics/Neonatology | ||||||
| 06/04/2018 | Mylan Specialty L.P. | Dymista (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Respiratory and Allergy | ||||||
| 05/30/2018 | Olympus America Inc. | ThunderBeat (Device) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Surgical Energy Products | ||||||
| 05/07/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Pediatrics/Neonatology | ||||||
| 05/07/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: Pediatrics/Neonatology | ||||||
| 04/16/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Pediatrics/Neonatology | ||||||
| 04/16/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: Pediatrics/Neonatology | ||||||
| 04/16/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: Pediatrics/Neonatology | ||||||
| 03/26/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Pediatrics/Neonatology | ||||||
| 03/26/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: Pediatrics/Neonatology | ||||||
| 03/12/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Pediatrics/Neonatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,189 | 1,458 | $399,036 | $125,022 |
| 2022 | 12 | 1,151 | 1,397 | $385,809 | $127,821 |
| 2021 | 9 | 725 | 835 | $207,841 | $75,545 |
| 2020 | 9 | 805 | 981 | $204,644 | $76,743 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 376 | 584 | $126,728 | $44,935 | 35.5% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 106 | 116 | $88,856 | $19,585 | 22.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 197 | 197 | $39,400 | $18,141 | 46.0% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 84 | 88 | $25,520 | $10,096 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $22,320 | $9,074 | 40.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 163 | 180 | $46,961 | $6,425 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 51 | $11,475 | $6,147 | 53.6% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2023 | 15 | 20 | $16,560 | $3,888 | 23.5% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 74 | 78 | $8,502 | $3,645 | 42.9% |
| 69200 | Removal of foreign body in ear canal | Office | 2023 | 21 | 21 | $8,787 | $1,642 | 18.7% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 26 | 42 | $2,730 | $1,146 | 42.0% |
| 92567 | Test to assess middle ear function | Office | 2023 | 19 | 19 | $1,197 | $296.21 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 353 | 544 | $118,048 | $43,996 | 37.3% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 113 | 126 | $96,516 | $22,536 | 23.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 194 | 194 | $38,800 | $19,929 | 51.4% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 71 | 75 | $21,750 | $8,631 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 73 | $16,425 | $8,220 | 50.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $16,200 | $6,649 | 41.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 157 | 173 | $42,884 | $6,543 | 15.3% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 88 | 93 | $10,137 | $4,454 | 43.9% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2022 | 13 | 15 | $12,420 | $3,041 | 24.5% |
| 69200 | Removal of foreign body in ear canal | Office | 2022 | 19 | 19 | $6,969 | $1,676 | 24.1% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2022 | 12 | 12 | $3,840 | $1,397 | 36.4% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 18 | 28 | $1,820 | $749.08 | 41.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 207 | 283 | $57,056 | $23,856 | 41.8% |
About Dr. Abraham Sinnreich, M.D
Dr. Abraham Sinnreich, M.D is a Otolaryngology healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518912781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abraham Sinnreich, M.D has received a total of $451.80 in payments from pharmaceutical and medical device companies, with $70.72 received in 2023. These payments were reported across 35 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($451.80).
As a Medicare-enrolled provider, Sinnreich has provided services to 3,870 Medicare beneficiaries, totaling 4,671 services with total Medicare billing of $405,131. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Oakhurst, NJ
- Active Since 05/24/2006
- Last Updated 02/28/2025
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1518912781
Products in Payments
- Otovel (Drug) $116.97
- Xhance (Drug) $85.30
- Dymista (Drug) $44.73
- DUPIXENT (Biological) $39.63
- Otiprio (Drug) $27.07
- ThunderBeat (Device) $20.69
- DS Cpap Auto Core-HT (Device) $17.34
- TULA System (Device) $16.26
- THROMBIN-JMI (Biological) $15.30
- CIPRODEX (Drug) $14.37
- Kloxxado (Drug) $11.80
- Evekeo (Drug) $11.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.